TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1403224

Group type: EXPERIMENTAL
Intervention: Evening class providing guidance on a self-help program for 2 hours on a group basis
Number of subjects: 224

Group type: COMPARATOR
Intervention: 20 minutes on an individual basis during the prenatal appointment
Number of subjects: 224
Study: 3908497

Group type: EXPERIMENTAL
Intervention: 0.03% aqueous solution of Sanguinaria extract (active mouthrinse)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo preparation (aqueous solution with similar color and taste)
Number of subjects: 14
Study: 31415914

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 53

Group type: COMPARATOR
Intervention: Midazolam (Control)
Number of subjects: 53
Study: 29249583

Group type: COMPARATOR
Intervention: Left‐sided double‐lumen endotracheal tube (DLT)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Bronchial blocker (BB)
Number of subjects: 45
Study: 26199275

Group type: EXPERIMENTAL
Intervention: Smartphone-based self-monitoring and health coaching for 6 months
Number of subjects: 11

Group type: COMPARATOR
Intervention: Health coaching without internet or smartphone-based assistance
Number of subjects: 11
Study: 23494455

Group type: EXPERIMENTAL
Intervention: Cone-beam computed tomography (CBCT)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Panoramic radiography (PAN)
Number of subjects: 256
Study: 21963214

Group type: EXPERIMENTAL
Intervention: Acute coronary syndrome presentation
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Proteomic analysis
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Paraoxonase-1
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Alpha-1-antichymotrypsin
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Alpha-1-antitrypsin
Number of subjects: 9
Study: 20446835

Group type: EXPERIMENTAL
Intervention: Elastic wrap
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Flex‐i‐Wrap
Number of subjects: 14

Group type: COMPARATOR
Intervention: No compression
Number of subjects: 14
Study: 17490971

Group type: EXPERIMENTAL
Intervention: Multivitamin supplementation
Number of subjects: 1078
Study: 15921471

Group type: EXPERIMENTAL
Intervention: Acupuncture (n=44)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Ultrasound (n=41)
Number of subjects: 85
Study: 12444398

Group type: EXPERIMENTAL
Intervention: Experimental denture adhesive
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Marketed denture adhesive (European Fixodent Fresh)
Number of subjects: 37

Group type: COMPARATOR
Intervention: No denture adhesive
Number of subjects: 37
Study: 10624908

Group type: EXPERIMENTAL
Intervention: Ketorolac 10 mg
Number of subjects: 17

Group type: COMPARATOR
Intervention: Acetaminophen 750 mg
Number of subjects: 17
Study: 8540713

Group type: EXPERIMENTAL
Intervention: Amphotericin B colloidal dispersion (dose levels ranging from 0.5 to 8.0 mg/kg of body weight)
Number of subjects: 75
Study: 1950383

Group type: EXPERIMENTAL
Intervention: Metoprolol (50 to 200 mg per day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 40
Study: 7045606

Group type: EXPERIMENTAL
Intervention: cinoxacin (500 mg every 12 hours)
Number of subjects: 63

Group type: COMPARATOR
Intervention: co-trimoxazole (160 mg trimethoprim, 800 mg sulphamethoxazole every 12 hours)
Number of subjects: 63
Study: 31623250

Group type: EXPERIMENTAL
Intervention: 0.25 g/kg bodyweight DSP
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 0.5 g/kg bodyweight DSP
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 360 g of 10% DSB
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 360 g of 15% DSB
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 30 mg/kg bodyweight DSE
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 60 mg/kg bodyweight DSE
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 16
Study: 30308973

Group type: EXPERIMENTAL
Intervention: Test-matcha (theanine-rich powdered green tea)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo-matcha (no expected effect)
Number of subjects: 39
Study: 27657985

Group type: EXPERIMENTAL
Intervention: Biosimilar recombinant human growth hormone (r-hGH; Somatotropin)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Reference recombinant human growth hormone (Genotropin®)
Number of subjects: 38
Study: 25906616

Group type: EXPERIMENTAL
Intervention: Music intervention for perceived stress
Number of subjects: 90
Study: 23204088

Group type: EXPERIMENTAL
Intervention: Sodium perborate mixed with distilled water (SP/W)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Sodium perborate mixed with 3 percent hydrogen peroxide (SP/HP‐3)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Sodium perborate mixed with 30 percent hydrogen peroxide (SP/HP‐30)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 35 percent hydrogen peroxide (HP‐35)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (C1) - unbleached specimens that did not receive calcium hydroxide dressing
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (C2) - unbleached specimens that did receive calcium hydroxide dressing
Number of subjects: 72
Study: 20378185

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Typical neuroleptics
Number of subjects: 0
Study: 17277729

Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg/day) for 6 weeks
Number of subjects: 13

Group type: COMPARATOR
Intervention: Healthy controls (not specified treatment)
Number of subjects: 13
Study: 15184937

Group type: EXPERIMENTAL
Intervention: 0.1% indomethacin, one drop three times a day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.1% diclofenac, one drop three times a day
Number of subjects: 20
Study: 12001776

Group type: EXPERIMENTAL
Intervention: 20 micrograms of EE + 150 micrograms of DSG
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 30 micrograms of EE + 150 micrograms of DSG
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both formulations
Number of subjects: 60
Study: 10460221

Group type: EXPERIMENTAL
Intervention: Testicular spermatozoa from men with obstructive azoospermia (n=20)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Proximal epididymal spermatozoa from men with obstructive azoospermia (n=20)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Testicular spermatozoa from men with obstructive azoospermia (n=39)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fertile men at vasectomy (n=10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ejaculated spermatozoa from controls (n=5)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Testicular spermatozoa from follow-up biopsy (n=9)
Number of subjects: 20
Study: 7794079

Group type: EXPERIMENTAL
Intervention: TRAM flap breast reconstruction with radiation treatment
Number of subjects: 680

Group type: COMPARATOR
Intervention: TRAM flap breast reconstruction without radiation treatment
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: TRAM flap breast reconstruction (both groups)
Number of subjects: 680
Study: 2240118

Group type: EXPERIMENTAL
Intervention: Auto Suture Poly CS 57 disposable surgical stapler
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard hysterectomy
Number of subjects: 200
Study: 285103

Group type: EXPERIMENTAL
Intervention: Caries-free children
Number of subjects: 0

Group type: COMPARATOR
Intervention: Caries-susceptible children
Number of subjects: 0
Study: 31151340

Group type: EXPERIMENTAL
Intervention: 42°C PRF combined with 60°C CRF
Number of subjects: 28
Study: 28860712

Group type: EXPERIMENTAL
Intervention: Oral morphine
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Oral oxycodone
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Transdermal fentanyl
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Transdermal buprenorphine
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: All opioids
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Prophylaxis of constipation (lactulose 10 mL twice daily)
Number of subjects: 62
Study: 25545655

Group type: EXPERIMENTAL
Intervention: Closed-loop (auto) group
Number of subjects: 42

Group type: COMPARATOR
Intervention: Manual (manual) group
Number of subjects: 42
Study: 22795617

Group type: EXPERIMENTAL
Intervention: Kirtan Kriya Meditation (KKM) for 12 min daily for 8 weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Relaxing Music (RM) listening for 12 min daily for 8 weeks
Number of subjects: 45
Study: 21078534

Group type: EXPERIMENTAL
Intervention: Educational intervention programme
Number of subjects: 185
Study: 19070681

Group type: EXPERIMENTAL
Intervention: Post-CONSORT period (2002-2007)
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Post-CONSORT studies
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Overall quality of reporting on psychiatric RCTs
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Reporting details of randomization, blinding, and obtaining informed consent
Number of subjects: 442
Study: 16112333

Group type: EXPERIMENTAL
Intervention: Robinson's Original Juice Drink at 4, 25, 50, and 75 degrees C
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Ribena ToothKind Juice Drink at 4, 25, 50, and 75 degrees C
Number of subjects: 2
Study: 15192072

Group type: EXPERIMENTAL
Intervention: rLH 75 IU daily from GnRH antagonist initiation to hCG injection
Number of subjects: 218

Group type: COMPARATOR
Intervention: Control group (no rLH supplementation)
Number of subjects: 218
Study: 11682661

Group type: EXPERIMENTAL
Intervention: Combination of ramipril and felodipine ER (R+F)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Ramipril (R)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Felodipine ER (F)
Number of subjects: 158
Study: 10771837

Group type: EXPERIMENTAL
Intervention: Hyperglycemia (glucose level > or = 150 mg/dl)
Number of subjects: 758

Group type: COMPARATOR
Intervention: Non-hyperglycemics
Number of subjects: 758

Group type: EXPERIMENTAL
Intervention: Hyperglycemia
Number of subjects: 758
Study: 8183660

Group type: EXPERIMENTAL
Intervention: Forced air warmer (Bair Hugger)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Noninfrared radiant heater (Thermal Ceiling)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Warm blankets
Number of subjects: 38
Study: 3277475

Group type: EXPERIMENTAL
Intervention: Intravenous amphotericin B (0.2 to 2 mg/kg total dose) for 2 to 6 days
Number of subjects: 224

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 224

Group type: COMPARATOR
Intervention: Antilymphocyte globulin-azathioprine
Number of subjects: 224

Group type: COMPARATOR
Intervention: Nystatin prophylaxis
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Candida esophagitis
Number of subjects: 224
Study: 30627885

Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation (109 colony-forming units) for 30 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo for 30 days
Number of subjects: 80
Study: 29708471

Group type: EXPERIMENTAL
Intervention: SMS for improving feeding practices
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control SMS about infant's general health issues
Number of subjects: 202
Study: 28807030

Group type: EXPERIMENTAL
Intervention: Metformin + Ascorbic Acid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metformin + Acetylsalicylic Acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metformin alone (Control)
Number of subjects: 0
Study: 26231516

Group type: EXPERIMENTAL
Intervention: Intervention arm of the Vitamin D and Osteoporosis Study (ViDOS)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Recommendations suggested by LTC teams
Number of subjects: 12
Study: 23715360

Group type: EXPERIMENTAL
Intervention: Salbutamol + Ipratropium bromide (3 doses of 2.5mg Salbutamol and 500mcg Ipratropium bromide)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Salbutamol only (3 doses of 2.5mg)
Number of subjects: 80
Study: 22019576

Group type: EXPERIMENTAL
Intervention: Acupuncture (24 sessions over 12 weeks)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Topiramate (4-week titration starting at 25 mg/day to a maximum of 100 mg/day followed by an 8-week maintenance)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 66

Group type: COMPARATOR
Intervention: Topiramate
Number of subjects: 66
Study: 17954698

Group type: EXPERIMENTAL
Intervention: Ceftobiprole 500 mg every 12 h
Number of subjects: 784

Group type: COMPARATOR
Intervention: Vancomycin 1 g every 12 h
Number of subjects: 784

Group type: EXPERIMENTAL
Intervention: Ceftobiprole for MRSA infections
Number of subjects: 784

Group type: COMPARATOR
Intervention: Vancomycin for MRSA infections
Number of subjects: 784

Group type: EXPERIMENTAL
Intervention: Ceftobiprole
Number of subjects: 784

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 784
Study: 17306393

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (RT) in addition to adjuvant systemic therapy
Number of subjects: 1152

Group type: COMPARATOR
Intervention: No postoperative radiotherapy (RT)
Number of subjects: 1152

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (RT)
Number of subjects: 1152
Study: 14973088

Group type: EXPERIMENTAL
Intervention: Green tea (4 cups/day)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Decaffeinated black tea (4 cups/day)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 133
Study: 11344044

Group type: EXPERIMENTAL
Intervention: Zoledronate (200 or 400 microg)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 9164811

Group type: EXPERIMENTAL
Intervention: Standard intravenous-feeding solutions
Number of subjects: 227

Group type: COMPARATOR
Intervention: Aluminum-depleted intravenous-feeding solutions
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Standard intravenous-feeding solutions (subgroup with no neuromotor impairment)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Aluminum-depleted intravenous-feeding solutions (subgroup with no neuromotor impairment)
Number of subjects: 227
Study: 8425433

Group type: COMPARATOR
Intervention: Ambulatory pH monitoring
Number of subjects: 255

Group type: COMPARATOR
Intervention: Stationary pH monitoring
Number of subjects: 255

Group type: COMPARATOR
Intervention: Both control groups (stationary and ambulatory)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Both patient groups (stationary and ambulatory)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Overall study completion
Number of subjects: 255
Study: 3315086

Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 30882151

Group type: EXPERIMENTAL
Intervention: bupropion
Number of subjects: 985

Group type: EXPERIMENTAL
Intervention: nicotine replacement therapy (NRT)
Number of subjects: 985

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 985

Group type: EXPERIMENTAL
Intervention: CHRNA5-CHRNA3-CHRNB4 variants
Number of subjects: 985

Group type: EXPERIMENTAL
Intervention: adherence to medication
Number of subjects: 985

Group type: EXPERIMENTAL
Intervention: successful smoking cessation
Number of subjects: 985
Study: 29735099

Group type: EXPERIMENTAL
Intervention: Roasted coffee beans (Arabica and robusta)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Classification models based on geographical origin
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Coffee volatile concentration
Number of subjects: 250
Study: 26563508

Group type: EXPERIMENTAL
Intervention: Artificial capnothorax (group P)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (group N)
Number of subjects: 48
Study: 24758521

Group type: EXPERIMENTAL
Intervention: CRT + non-invasive extracorporeal radiofrequency (ERF)
Number of subjects: 83

Group type: COMPARATOR
Intervention: CRT
Number of subjects: 83
Study: 22228231

Group type: EXPERIMENTAL
Intervention: RIX4414
Number of subjects: 1009

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1009
Study: 20160655

Group type: EXPERIMENTAL
Intervention: Music-guided slow breathing exercises (4-6 breaths/min; 1:2 ratio of inspiration: expiration duration)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control-M (listening to slow music)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control-R (reading a book)
Number of subjects: 86
Study: 18515918

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol (SMART)
Number of subjects: 3335

Group type: COMPARATOR
Intervention: Fixed higher-dose budesonide/formoterol (FHDBF)
Number of subjects: 3335

Group type: COMPARATOR
Intervention: Fixed dose fluticasone/salmeterol (FDFS)
Number of subjects: 3335
Study: 16223399

Group type: EXPERIMENTAL
Intervention: 50 mg of magnesium sulphate 5% (1.0 ml)
Number of subjects: 102

Group type: COMPARATOR
Intervention: 1.0 ml of preservative‐free 0.9% sodium chloride
Number of subjects: 102
Study: 12141771

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate
Number of subjects: 12

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 12
Study: 10208945

Group type: COMPARATOR
Intervention: 5 mg of salbutamol by jet nebuliser
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Up to 10 puffs of salbutamol 100 microg by metered dose inhaler and spacer
Number of subjects: 61
Study: 8586752

Group type: EXPERIMENTAL
Intervention: Blend method (permanent hair removal)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Plucking (temporary hair removal)
Number of subjects: 14
Study: 1693335

Group type: EXPERIMENTAL
Intervention: Low dose oral treatment
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High dose oral treatment
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Subcutaneous hyposensitization regime
Number of subjects: 60
Study: 606781

Group type: EXPERIMENTAL
Intervention: Inactivated influenza A/New Jersey/X-53 subunit virus vaccine (100 or 200 CCA units for children ≤9 years; 200 or 400 CCA units for children >9 years), administered intramuscularly in two doses at intervals of four weeks.
Number of subjects: 103
Study: 31046541

Group type: EXPERIMENTAL
Intervention: Omalizumab
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Mepolizumab
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Reslizumab
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Benralizumab
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Dupilumab
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 31078191

Group type: EXPERIMENTAL
Intervention: CCNP + RE
Number of subjects: 87

Group type: COMPARATOR
Intervention: RE
Number of subjects: 87
Study: 28796648

Group type: EXPERIMENTAL
Intervention: Slow robot-assisted locomotor training
Number of subjects: 18

Group type: COMPARATOR
Intervention: Fast robot-assisted locomotor training
Number of subjects: 18
Study: 26226884

Group type: EXPERIMENTAL
Intervention: Donepezil (3, 5, and 10 mg)
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Donepezil (5 and 10 mg)
Number of subjects: 281

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 281
Study: 23536583

Group type: EXPERIMENTAL
Intervention: Intensive glucose-lowering therapy (INT)
Number of subjects: 266
Study: 21959068

Group type: EXPERIMENTAL
Intervention: Valerian (255 mg, 3 times daily for 3 days)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Valerian
Number of subjects: 100
Study: 18810398

Group type: EXPERIMENTAL
Intervention: Methylene blue (MB) 500 mg orally
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Methylene blue (MB) 500 mg orally combined with chloroquine (CQ) 750 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Methylene blue (MB) 50 mg intravenous (i.v.)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Chloroquine (CQ) 750 mg administered orally alone
Number of subjects: 16
Study: 17971947

Group type: EXPERIMENTAL
Intervention: ADV 10 mg/d for 48 weeks
Number of subjects: 226

Group type: COMPARATOR
Intervention: Placebo for 24 weeks followed by ADV 10 mg/d for 24 weeks
Number of subjects: 226
Study: 15512809

Group type: EXPERIMENTAL
Intervention: 500 mg valacyclovir orally every 8 h
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: 1,000 mg valacyclovir orally every 8 h
Number of subjects: 81
Study: 11368294

Group type: EXPERIMENTAL
Intervention: ZD1839 (1 to 75mg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: ZD1839 (100mg once daily for 3 days)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Single 50mg dose of ZD1839 with food
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 9487372

Group type: EXPERIMENTAL
Intervention: Single dose total-body irradiation (STBI) - 10 Gy to midplane, 8 Gy to lungs
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Fractionated total-body irradiation (FTBI) - 12 Gy on 3 consecutive days, 9 Gy to lungs
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: LOW instantaneous dose rate group (< or = 0.048 Gy/min)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: MEDIUM instantaneous dose rate group (> 0.048 and < or = 0.09 Gy/min)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: HIGH instantaneous dose rate group (> 0.09 Gy/min)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Allogeneic BMT
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Autologous BMT
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Graft-vs-host disease (GvHD)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Treatment after 1985
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Cataract incidence influenced by instantaneous dose rate
Number of subjects: 326
Study: 8306272

Group type: EXPERIMENTAL
Intervention: 131I-Mu-9 immunoglobulin G
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 131I-F(ab')2
Number of subjects: 25

Group type: COMPARATOR
Intervention: Both 131I-Mu-9 immunoglobulin G and 131I-F(ab')2
Number of subjects: 25
Study: 3178928

Group type: EXPERIMENTAL
Intervention: Maxepa (3.24 g eicosapentaenoic acid and 2.16 g docosahexaenoic acid per day)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Maxepa
Number of subjects: 25

Group type: COMPARATOR
Intervention: Safflower oil (control)
Number of subjects: 25
Study: 824725

Group type: EXPERIMENTAL
Intervention: Diftalone 500 mg/day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Indomethacin 50-75 mg/day initially and 100 mg/day subsequently
Number of subjects: 30
Study: 31118245

Group type: EXPERIMENTAL
Intervention: Efgartigimod (10 mg/kg IV)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 28378467

Group type: EXPERIMENTAL
Intervention: Ephedrine (6 mg boluses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Phenylephrine (50 μg boluses)
Number of subjects: 0